Abbott (ABT) Tops Q3 EPS by 8c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
Abbott Labs (ABT) PT Raised to $113 at Cowen Into Q3 Results
October 19, 2020 5:48 PM EDTCowen analyst Joshua Jennings raised the price target on Abbott Labs (NYSE: ABT) to $113.00 (from $105.00) while maintaining an Outperform rating ahead of Q3 results.
The analyst commented, "Ahead of ABT's 3Q report on October 21, we're raising our 2H'20 forecasts to better... More



